A detailed history of Investors Research Corp transactions in Baxter International Inc stock. As of the latest transaction made, Investors Research Corp holds 12,951 shares of BAX stock, worth $514,413. This represents 0.1% of its overall portfolio holdings.

Number of Shares
12,951
Previous 12,951 -0.0%
Holding current value
$514,413
Previous $553,000 21.7%
% of portfolio
0.1%
Previous 0.13%

Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 06, 2024

SELL
$37.88 - $43.77 $16,099 - $18,602
-425 Reduced 3.18%
12,951 $553,000
Q4 2023

Jan 30, 2024

BUY
$31.71 - $38.95 $422,726 - $519,242
13,331 Added 29624.44%
13,376 $517,000
Q1 2022

Apr 13, 2022

BUY
$76.85 - $89.45 $3,458 - $4,025
45 New
45 $3,000
Q2 2020

Jul 21, 2020

SELL
$78.66 - $94.14 $15,024 - $17,980
-191 Closed
0 $0
Q3 2019

Oct 22, 2019

BUY
$81.4 - $89.78 $9,849 - $10,863
121 Added 172.86%
191 $17,000
Q1 2019

Apr 23, 2019

BUY
$64.48 - $81.31 $4,513 - $5,691
70 New
70 $6,000

Others Institutions Holding BAX

About BAXTER INTERNATIONAL INC


  • Ticker BAX
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 504,120,992
  • Market Cap $20B
  • Description
  • Baxter International Inc., through its subsidiaries, develops and provides a portfolio of healthcare products worldwide. The company offers peritoneal dialysis and hemodialysis, and additional dialysis therapies and services; intravenous therapies, infusion pumps, administration sets, and drug reconstitution devices; remixed and oncology drug pl...
More about BAX
Track This Portfolio

Track Investors Research Corp Portfolio

Follow Investors Research Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Investors Research Corp, based on Form 13F filings with the SEC.

News

Stay updated on Investors Research Corp with notifications on news.